| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6145324 | American Journal of Obstetrics and Gynecology | 2015 | 7 Pages |
Abstract
LIP localized within the uterus and did not cross the placenta to the fetus. IND within the fetus was reduced 7.6-fold while encapsulated within the LIP and the pharmacologic effects of IND were maintained. Thus, LIP provide a novel therapeutic approach to correct the primary clinical limitation of IND by reducing placental passage to the fetus.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jerrie S. MD, Jenolyn F. MSc, Fransisca PhD, Mateo MD, Monica MD, PhD, Biana MScPharm, PhD,